Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Mulec

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
BMJ (Clinical Research Ed.)|February 8, 1992
Renal protective effect of enalapril in diabetic nephropathyS Björck, H Mulec, S A Johnsen, et al.
British Medical Journal (Clinical Research Ed.)|August 23, 1986
Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathyS Björck, G Nyberg, H Mulec, et al.
Scandinavian Journal of Urology and Nephrology|October 9, 1998
Effects of ticlopidine in AV-fistula surgery in uremia. Fistula Study GroupK C Gröntoft, R Larsson, H Mulec, et al.
Kidney International|March 31, 2006
Effect of fluvastatin on apolipoprotein-defined lipoprotein subclasses in patients with chronic renal insufficiencyP Alaupovic, P-O Attman, C Knight-Gibson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 23, 2000
Angiotensin I-converting enzyme gene polymorphism in non-diabetic renal diseaseO Samuelsson, P O Attman, R Larsson, et al.
Journal of the American Society of Nephrology : JASN|August 11, 1998
Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiencyO Samuelsson, P O Attman, C Knight-Gibson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 1, 1996
Plasma levels of lipoprotein (a) do not predict progression of human chronic renal failureO Samuelsson, P O Attman, C Knight-Gibson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Lipoprotein abnormalities without hyperlipidaemia in moderate renal insufficiencyO Samuelsson, P O Attman, C Knight-Gibson, et al.
Nephron|January 1, 1997
Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal diseaseO Samuelsson, P O Attman, C Knight-Gibson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 5, 1997
Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiencyO Samuelsson, H Mulec, C Knight-Gibson, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
BMJ (Clinical Research Ed.)|February 8, 1992
Renal protective effect of enalapril in diabetic nephropathyS Björck, H Mulec, S A Johnsen, et al.
British Medical Journal (Clinical Research Ed.)|August 23, 1986
Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathyS Björck, G Nyberg, H Mulec, et al.
Scandinavian Journal of Urology and Nephrology|October 9, 1998
Effects of ticlopidine in AV-fistula surgery in uremia. Fistula Study GroupK C Gröntoft, R Larsson, H Mulec, et al.
Kidney International|March 31, 2006
Effect of fluvastatin on apolipoprotein-defined lipoprotein subclasses in patients with chronic renal insufficiencyP Alaupovic, P-O Attman, C Knight-Gibson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 23, 2000
Angiotensin I-converting enzyme gene polymorphism in non-diabetic renal diseaseO Samuelsson, P O Attman, R Larsson, et al.
Journal of the American Society of Nephrology : JASN|August 11, 1998
Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiencyO Samuelsson, P O Attman, C Knight-Gibson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 1, 1996
Plasma levels of lipoprotein (a) do not predict progression of human chronic renal failureO Samuelsson, P O Attman, C Knight-Gibson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Lipoprotein abnormalities without hyperlipidaemia in moderate renal insufficiencyO Samuelsson, P O Attman, C Knight-Gibson, et al.
Nephron|January 1, 1997
Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal diseaseO Samuelsson, P O Attman, C Knight-Gibson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 5, 1997
Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiencyO Samuelsson, H Mulec, C Knight-Gibson, et al.
Pageof 3